Ipsen’s Post

At Roche, our purpose is clear: to put patients first and make a positive impact on society. Our Operating Principles guide us every step of the way: ➡️ Follow the Science ➡️ Put Patients First ➡️ Act as One Team ➡️ Embrace Differences ➡️ Accelerate Learning ➡️ Simplify Radically ➡️ Make Impact Now ➡️ Think Long Term These principles are more than just words; they're the foundation of how we work and innovate together. Together, we're shaping a healthier, brighter future for all. #roche #Roche_Operating_Principles #Health_care_Innovation #Teamwork #Impact #Diversity_And_Inclusion

📣🎉 We are beyond thrilled to announce the newest addition to our XO Life family: Jochen Hurlebaus as our 𝐂𝐡𝐢𝐞𝐟 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐎𝐟𝐟𝐢𝐜𝐞𝐫 𝐚𝐧𝐝 𝐕𝐏 𝐂𝐥𝐢𝐞𝐧𝐭 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬! Jochen will be spearheading our ambitious international expansion and strategic partnerships. 🙌 With a remarkable background as the former Head of Digital Health Innovation at Roche Diagnostics International, Jochen brings 𝐨𝐯𝐞𝐫 20 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐢𝐧𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. 🚀 With Jochen at the forefront, we are excited to 𝐭𝐚𝐤𝐞 𝐗𝐎 𝐋𝐢𝐟𝐞 𝐭𝐨 𝐧𝐞𝐰 𝐡𝐞𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐞𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐢𝐧𝐭𝐨 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐬. This expansion is not just about growth; it’s about 𝐦𝐚𝐤𝐢𝐧𝐠 𝐚 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐧 𝐠𝐥𝐨𝐛𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡. By adapting our marketing and user acquisition strategies to fit diverse markets, we can deliver faster, higher-quality support to patients around the world. Our goal is to ensure that everyone, regardless of their location, has access to the top-notch digital therapy and product support they need. 🌍 This international expansion means more than just entering new markets. 𝐈𝐭’𝐬 𝐚𝐛𝐨𝐮𝐭 𝐥𝐞𝐯𝐞𝐫𝐚𝐠𝐢𝐧𝐠 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 𝐭𝐨 𝐞𝐧𝐡𝐚𝐧𝐜𝐞 𝐭𝐡𝐞 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐫𝐞𝐚𝐜𝐡 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬. By working closely with multinational partners, we aim to bring the successful ImpactMonitor platform to patients across various regions, ensuring they benefit from the same level of care and innovation that our current users enjoy. 🥳 With Jochen’s leadership, we are confident that XO Life will continue to set 𝐧𝐞𝐰 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 𝐢𝐧 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐚𝐫𝐞 𝐚𝐧𝐝 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. His vision aligns perfectly with our mission to create a safe, engaging, and informative digital environment for all patients. 😎 Stay tuned for more exciting updates as we continue to grow and innovate because: 𝐖𝐞 𝐤𝐞𝐞𝐩 𝐦𝐨𝐯𝐢𝐧𝐠 𝐮𝐧𝐭𝐢𝐥 𝐞𝐯𝐞𝐫𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐠𝐞𝐭𝐬 𝐭𝐡𝐞 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐚𝐧𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐞𝐲 𝐝𝐞𝐬𝐞𝐫𝐯𝐞. 🤝 #xolife #digitalhealth #patientcare #healthinnovation #ImpactMonitor #globalexpansion #strategicpartnerships #ChiefStrategyOfficer #pharma #digitaltransformation

Kicking Off the #NewYear #Together: Merz Lifecare and WindStar Medical Join Forces! We couldn’t imagine a better way to start 2025! As of January 1, our merger is official—a historic milestone that nearly doubles our business, strengthens our market presence, and sharpens our focus on health-oriented product portfolios. What’s changing—and what’s staying the same? ▶️ Unified under one roof: Merz Lifecare and WindStar Medical are now united under the newly formed Merz Lifecare Holding GmbH. The managing directors of the holding company are Xenia Barth (CEO Merz Lifecare) and Steven Potschull (COO Merz Lifecare). ▶️ Strong brands, even stronger future: We will continue to develop our trusted brands, including tetesept, Merz Spezial, SOS, and Zirkulin, to offer an even broader and more impactful range of health products for our customers and consumers. ▶️ Private label expertise remains: Dr. Kleine Pharma, a WindStar Medical company, will continue to lead the private label segment and is now part of Merz Lifecare Holding GmbH. We’re thrilled to collaborate with our new WindStar Medical Group colleagues and exchange ideas as we work toward becoming a major player in the OTC market across the DACH region. Could there possibly be a better way to kick off the new year? Let’s make it happen together! 👉Further information can be found here in the press release: https://lnkd.in/ekjjuA4q #MerzLifecare #WindStar #UnitedForHealth

As we wrap up 2024, we reflect on a year of growth, achievements, and new beginnings at Innvocept Global Solutions.    This year has been particularly special, as we celebrated 5 years of Innvocept’s journey—a journey driven by innovation, collaboration, and an unwavering commitment to excellence. Key milestones of the past 5 years include:    > Market Share Growth: Achieved ₹22.12 crore in revenue, with a CAGR of 82.56%, reflecting our growing market presence and strong performance.   > Formation of Board of Directors: Established a strategic Board of Directors to provide governance and guide us into the next phase of growth.   > Project Success: Awarded 63 projects, with over 40 successfully completed, showcasing our ability to deliver results.   > Global Reach: Expanded our client base across the US, EU, and APAC, strengthening our global presence and unlocking new opportunities.   > Service Line Growth: Enhanced our capabilities in Clinical Operations, Biometrics, and Medical Writing, solidifying our leadership in multi-domain E2E CRO services.   Immediate Focus Areas (2025 & Beyond):   > US Market Expansion: Poised for deeper market penetration and continued growth in the US.   > Strategic Partnerships: Finalizing partnerships that will drive innovation and accelerate growth.   > Investor Engagement: Engaged in active discussions for bridge funding, pre-series and Series A investments ensuring the necessary resources to support our ongoing expansion   We’re excited about what lies ahead and are gearing up for an exciting start to 2025—stay tuned for updates in January!    We extend our heartfelt thanks to our incredible team, clients, and well-wishers who have been integral to our success. Here’s to continued growth and shared success in the coming year.    #5YearsOfInnvocept #Leadership #Growth #Gratitude #Innovation #NewBeginnings

🌐 Together We Thrive: The Heartbeat of Our SMO—Founders and Core Teams United In the specialized world of clinical research, Site Management Organizations (SMOs) stand out for their unique focus and operational prowess. Here at our SMO, the collaboration between founders and dedicated core teams isn't just beneficial—it's essential to navigating this complex field. 🤝 Unity in Vision: Our shared vision propels us forward, ensuring that everyone from the top down is aligned and energized to achieve common goals. 🔄 Strength in Diversity: Our founders bring vision; our teams bring vitality. Each person’s skills contribute to our collective ability to manage trials with exceptional precision and care. 💡 Collective Wisdom: Decision-making here benefits from diverse perspectives, blending founder insights with the hands-on experiences of our core team. This approach ensures robust, practical strategies that stand up to the demands of clinical trials. 🔗 Building Trust: Strong internal partnerships enhance our external credibility. Clients and stakeholders trust us because they see a cohesive and competent team managing every aspect of the trials. 🌟 Growth and Mentorship: Leadership extends beyond strategic decisions; it's about fostering a culture of mentorship and continuous learning. We’re committed to professional growth, helping everyone reach their full potential. 📈 Operational Excellence: Our SMO excels in managing clinical trials with an efficiency that sets us apart. We specialize in navigating regulatory environments, leveraging technology to streamline processes, and ensuring participant engagement from start to finish. 🔍 Unique SMO Capabilities: Expertise in Clinical Trials: Unlike broader healthcare or research organizations, our core focus is managing the intricacies of clinical trials. Adaptive Operations: We are adept at scaling operations to match trial needs, ensuring flexibility and efficiency. Technological Integration: We harness cutting-edge technology to maintain high standards of data management and participant tracking. Cost Efficiency: Our focused expertise allows us to conduct trials more cost-effectively, providing value to our partners and stakeholders. Together, we not only meet the unique challenges of clinical trials but set new standards in research excellence. Let’s continue to champion the strength of our combined efforts. #Leadership #ClinicalResearch #SMO #Partnership #Teamwork #HealthcareInnovation #DPHS DPHS Dr. Ankesh Pawar Gayatri Khandagale Sanket Ambarkhane Sumit Hingmire Mohan Sirsat

At Organon, we are leading the change we want to see reflected in the world. As we look ahead to next year, Organon’s global leaders are sharing their insights on what we can expect to look forward to in 2025. In this installment, hear from: ▪️ Juan Camilo Arjona Ferreira, M.D., Head of Research & Development and Chief Medical Officer ▪️ Aaron Falcione, Chief Human Resources Officer ▪️ Colby Holtshouse, Global MedTech Commercial Lead Stay tuned for more 2025 trend predictions from our leaders as we close 2024. #WomensHealth #HealthcareInnovation #2025Trends

As the year winds down, we’ve been reflecting on the progress and partnerships that have shaped 2024. Among the highlights is the privilege of collaborating with Emre Ozcan, PhD, SVP and Global Head of Digital Health & Devices at Merck Healthcare, whose leadership and vision are truly inspiring. In a recent interview, Emre shared how his upbringing and life experiences motivated him to focus on healthcare transformation. He spoke passionately about the power of digital health to enable value-based systems, enhance patient outcomes, and bridge gaps in access. His vision for the future is bold: a world where care is seamless and digital health becomes an integral part of it. As he aptly put it, those who embrace digital innovation thoughtfully and at scale will lead the transformation of healthcare as we know it. We invite you to watch this short video and gain insights into Emre’s remarkable journey and his thoughts on the future of care. Thank you to Emre for sharing his time with us, and to the talented team he leads at Merck. Their relentless commitment turns vision into reality. Vincenzo Tornincasa, Merck Group, EMD Serono, Inc. #CodeToSaveLives #DigitalHealth #HealthcareTransformation 

How Can We Better Support Sites in Clinical Trial? At Innovation Network Gathering, we recognize the critical role sites play in clinical trials. They are key partners, not mere service providers, and understanding their importance is crucial for sponsors as well. In 2023 Main Stage Talk, Rosalie Filling, Vice President, Senior Global Head R&D Operations at Endo shared insights on actionable steps sponsors can take to strengthen relationships with sites. Rosie’s message remains as relevant as ever, and we’ll be diving deeper into this topic at this year’s Dive Teams. Watch Rosie's full talk, “We Need Sites More Than They Need Us” https://lnkd.in/gS798Y7Q 💌 Visit our website to learn more about the Gathering https://lnkd.in/gEvbtCWY 👥 Who do you think shouldn't miss this year's conversation? Tag them in the comments! #Sites #Innovation #Gathering2024

What's your impulse? Share your thoughts ideas, motivations and goals for the future of healthcare using the hashtag #WhatsYourImpulse! Join us as we work together to shape a brighter future for everyone: https://lnkd.in/en-CBWZJ. #TheImpulse #ChiesiGroup #HealthcareInnovation